Chiropractic Offers Long Term Benefits for Fibromyalgia Sufferers

If you suffer from fibromyalgia, you are not alone, as Dr. Pittman sees many patients with this particular condition in our San Angelo chiropractic clinic. As a matter of fact, the Centers for Disease Control and Prevention (CDC) estimates that roughly two percent of all adults in the US have fibromyalgia. Thankfully, chiropractic care is one treatment option that can provide positive results.

Research Shows Chiropractic Eases Fibromyalgia

In a medical study released in mid-2015, 215 women and men with fibromyalgia were evaluated based on factors ranging from pain to quality of sleep to the levels of depression symptoms or anxiety they felt. Then they were split into two groups with one group receiving a multi-modal treatment plan for three months and the second group receiving the same approach with the addition of chiropractic adjustments (specifically, to the upper neck tissues) for the same length of time.

The individuals who received chiropractic care in addition to the multi-disciplinary treatment approach reported greater results in all areas (pain, sleep, depression, and anxiety) at three months post-treatment when compared to the study participants who received multi-modal treatment without chiropractic care. Additionally, those positive results were long-lasting as the individuals reported continued improvement one full year later.

Fibromyalgia can substantially reduce your quality of life, both psychologically and physically. If you're suffering from fibromyalgia, we might be able to help.

You don't have to suffer! To see what Dr. Pittman can do for your fibromyalgia pain, call our San Angelo chiropractic office today.

Studies

• Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
• Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.